Serge Golden

Serge Golden has extensive work experience in the pharmaceutical industry, with a focus on clinical strategic sourcing and outsourcing. Serge currently holds the position of Senior Director, Clinical Strategic Sourcing at Boston Pharmaceuticals since September 2022. Prior to this, Serge worked at Alexion Pharmaceuticals, Inc. as an Associate Director R&D Outsourcing from November 2018 to September 2022. In this role, they managed the identification and selection process of R&D vendors, led negotiations with new vendors, and supported a clinical portfolio consisting of multiple Phase III studies. Before joining Alexion, Serge held positions at ImmunoGen, Inc. as an Associate Director Clinical Outsourcing (Contractor), Shire Pharmaceuticals as a Sr. Manager Clinical Outsourcing, and Cerulean Pharma Inc. as the Head of Clinical Business Operations. Serge also gained experience at Novartis Institutes for BioMedical Research, Novartis Translational Sciences, Finance, Novartis Institutes for BioMedical Research, Boston University School of Management, UCB, and Millennium Pharmaceuticals. Serge's expertise includes budgeting, forecasting, trial operations, and strategic management.

Serge Golden pursued their education at the University of Rhode Island from 1986 to 1990, where they obtained a Bachelor of Science (BS) degree in Biotechnology. Serge'seducational journey continued in 2013 at the Questrom School of Business, Boston University, where they undertook an Executive MBA program. Serge completed this program in 2015, specializing in Business Administration and Management, General.